Last updated on February 2020

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC

Brief description of study

The purpose of this study is to determine whether Nivolumab, Ipilimumab combined with chemotherapy is more effective than chemotherapy by itself when treating stage IV NSCLC as the first treatment given for the disease

Clinical Study Identifier: NCT03215706

Find a site near you

Start Over

Local Institution

Osaka-sayama-shi, Japan
  Connect »

Local Institution

Habikino-shi, Japan
  Connect »